These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3084757)

  • 21. Transdermal bioavailability and first-pass skin metabolism: a preliminary evaluation with nitroglycerin.
    Nakashima E; Noonan PK; Benet LZ
    J Pharmacokinet Biopharm; 1987 Aug; 15(4):423-37. PubMed ID: 3119815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pattern of glyceryl nitrates after oral administration of glyceryl trinitrate.
    Laufen H; Leitold M
    Arzneimittelforschung; 1988 Jan; 38(1):103-5. PubMed ID: 3130064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative bioavailability of a new transdermal nitroglycerin delivery system.
    Noonan PK; Gonzalez MA; Ruggirello D; Tomlinson J; Babcock-Atkinson E; Ray M; Golub A; Cohen A
    J Pharm Sci; 1986 Jul; 75(7):688-91. PubMed ID: 3093667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of nitroglycerin and long-acting nitrate esters.
    Fung HL
    Am J Med; 1983 Jun; 74(6B):13-20. PubMed ID: 6407312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of nitroglycerin in the beagle dog after intravenous and buccal administration.
    Ritschel WA; Shaaya AN; Tan HS
    Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):307-13. PubMed ID: 3932795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers.
    Noonan PK; Williams RL; Benet LZ
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):143-57. PubMed ID: 3932639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Strain-gauge plethysmographic measurement of the systemic bioavailability of oral nitroglycerin in liver cirrhosis].
    Sabba' C; Pugliese D; Carbone P; Altomare E; Portincasa P; Buonamico P; Stufano N; D'Ercole M; Palasciano G; Albano O
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1825-31. PubMed ID: 6422959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of nitroglycerin ointments in the rabbit.
    Ritschel WA; Ritschel-Beurlin G; Grummich K
    Arzneimittelforschung; 1980; 30(3):432-5. PubMed ID: 6770874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment.
    Chu LC; Gale RM; Schmitt LG; Shaw JE
    Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative bioavailability of two spray formulations of nitroglycerin.
    Sanders SW; Michaelis K; Maurette JM; Jaeger H
    J Pharm Sci; 1986 Mar; 75(3):244-6. PubMed ID: 3084758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biopharmaceutical evaluation of methylcellulose as an excipient for nitroglycerin tablets.
    Shibuya F; Kuramoto K; Koizumi H; Uehara N; Nakagawa F; Tamura Z; Murayama M; Kawakubo K; Kawahara T; Ohshiro M
    J Pharmacobiodyn; 1985 May; 8(5):352-6. PubMed ID: 3930694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of nitroglycerin in human blood after administration by sustained release.
    Givant Y; Sulman FG
    Experientia; 1978 May; 34(5):643-4. PubMed ID: 95967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption kinetics of dihydroergotoxine following oral administration to man.
    Woodcock BG; Rietbrock N; Loh W; Habedank WD
    Br J Clin Pharmacol; 1985 Dec; 20(6):603-9. PubMed ID: 4091992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
    Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
    Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasma levels of nitroglycerin after oral and percutaneous administration (author's transl)].
    Girre C; Crouzette J; Fournier PE
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2433-6. PubMed ID: 6775295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of glyceryl trinitrate: effects of sex, age, species and route of administration.
    Ioannides C; Parke DV; Taylor IW
    Br J Pharmacol; 1982 Sep; 77(1):83-8. PubMed ID: 6812676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bioavailability of glycerol trinitrate (nitroglycerin) from an ointment preparation].
    Gielsdorf W; Schlegel E; Settlage JA; Jaeger H; Fink E
    Arzneimittelforschung; 1983; 33(12):1677-9. PubMed ID: 6421295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure.
    Moe G; Armstrong PW
    Am J Med; 1986 Nov; 81(5):765-70. PubMed ID: 3096133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effects of isosorbide dinitrate vs nitroglycerin in patients with unstable angina.
    Willis WH; Russell RO; Mantle JA; Ratshin RA; Rackley CE
    Chest; 1976 Jan; 69(1):15-22. PubMed ID: 811427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
    Savonitto S; Motolese M; Agabiti-Rosei E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.